商品标签为：'雷奈佐利'
浏览为
排序由
显示 每页
利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；≥98% (HPLC)
PZ0014
![图片 利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；≥98% (HPLC)](https://www.bszh.cn/images/thumbs/0000896_-linezolid98-hplc_415.png "显示明细 利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；≥98% (HPLC)")
别名：吗啉恶酮；利奈唑烷；N-[[（5S）-3-[3-氟-4-（4-吗啉基）苯基] -2-氧代-5-恶唑烷基]甲基]乙酰胺；N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide；PNU-100766；U-100766
Empirical Formula (Hill Notation): C16H20FN3O4 CAS号: 165800-03-3 分子量: 337.35 MDL编号: MFCD00937825 PubChem化学物质编号: 329823683 NACRES: NA.77
Empirical Formula (Hill Notation): C16H20FN3O4 CAS号: 165800-03-3 分子量: 337.35 MDL编号: MFCD00937825 PubChem化学物质编号: 329823683 NACRES: NA.77
利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；≥99.0% (HPLC)
L04839
![图片 利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；≥99.0% (HPLC)](https://www.bszh.cn/images/thumbs/0004526_-linezolid990-hplc_415.png "显示明细 利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；≥99.0% (HPLC)")
别名：吗啉恶酮；利奈唑烷；N-[[（5S）-3-[3-氟-4-（4-吗啉基）苯基] -2-氧代-5-恶唑烷基]甲基]乙酰胺；N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide；PNU-100766；U-100766
Empirical Formula (Hill Notation): C16H20FN3O4 CAS号: 165800-03-3 分子量: 337.35 MDL编号: MFCD00937825 PubChem化学物质编号: 329823683 NACRES: NA.77
Empirical Formula (Hill Notation): C16H20FN3O4 CAS号: 165800-03-3 分子量: 337.35 MDL编号: MFCD00937825 PubChem化学物质编号: 329823683 NACRES: NA.77
利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；Pharmaceutical Secondary Standard; Certified Reference Material
PHR1885
![图片 利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；Pharmaceutical Secondary Standard; Certified Reference Material](https://www.bszh.cn/images/thumbs/0015110_-linezolidpharmaceutical-secondary-standard-certified-reference-material_415.png "显示明细 利奈唑胺 [雷奈佐利, 利奈唑酮]，Linezolid；Pharmaceutical Secondary Standard; Certified Reference Material")
别名：利奈唑胺标准品；吗啉恶酮；利奈唑烷；N-[[（5S）-3-[3-氟-4-（4-吗啉基）苯基] -2-氧代-5-恶唑烷基]甲基]乙酰胺；N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide；PNU-100766；U-100766
Empirical Formula (Hill Notation): C16H20FN3O4 CAS号: 165800-03-3 分子量: 337.35 MDL编号: MFCD00937825 NACRES: NA.24
Empirical Formula (Hill Notation): C16H20FN3O4 CAS号: 165800-03-3 分子量: 337.35 MDL编号: MFCD00937825 NACRES: NA.24
最近浏览商品
-
![图片 人纤维蛋白原，Fibrinogen from human plasma [Factor I]；50-70% protein (≥80% of protein is clottable)](https://www.bszh.cn/images/thumbs/0015678_fibrinogen-from-human-plasma-factor-i50-70-protein-80-of-protein-is-clottable_32.webp "显示明细 人纤维蛋白原，Fibrinogen from human plasma [Factor I]；50-70% protein (≥80% of protein is clottable)")
人纤维蛋白原，Fibrinogen from human plasma [Factor I]；50-70% protein (≥80% of protein is clottable) -
4-甲基水杨酸，4-Methylsalicylic acid；99% -
γ-球蛋白来源于小鼠血液，γ-Globulins from mouse blood；≥90% (agarose gel electrophoresis) -
D-酪氨酸，D-Tyrosine；ReagentPlus®, 99% -
![图片 (−)-氧化石竹烯，(−)-Caryophyllene oxide [BCPO]；analytical standard, ≥98.5% (GC)](https://www.bszh.cn/images/thumbs/0009447_-caryophyllene-oxide-bcpoanalytical-standard-985-gc_32.jpeg "显示明细 (−)-氧化石竹烯，(−)-Caryophyllene oxide [BCPO]；analytical standard, ≥98.5% (GC)")
(−)-氧化石竹烯，(−)-Caryophyllene oxide [BCPO]；analytical standard, ≥98.5% (GC) -
2,2′,4,4′,6-五溴二苯醚，2,2',4,4',6-Pentabromodiphenyl Ether
